Ampofo W, Nii-Trebi N, Ansah J, Abe K, Naito H, Aidoo S, Nuvor V, Brandful J, Yamamoto N, Ofori-Adjei D, and Ishikawa K conducted a study titled "Prevalence of blood-borne infectious diseases in blood donors in Ghana," published in Journal of Clinical Microbiology in 2002. Their research focused on identifying the prevalence of blood-borne infections such as HIV, hepatitis B (HBV), hepatitis C (HCV), and syphilis among blood donors in Ghana.
In another study by Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, and Sack U, titled "Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years," published in BMC Infectious Diseases in 2010, the authors reported a decrease in the seroprevalence of these infections over five years in blood donors in Ethiopia.
Torane VP and Shastri JS, in their 2008 study "Comparison of ELISA and rapid screening tests for the diagnosis of HIV, hepatitis B and hepatitis C among healthy blood donors in a tertiary care hospital in Mumbai," published in Indian Journal of Medical Microbiology, compared the efficiency of ELISA and rapid screening tests for detecting these infections.
Chen PJ, Chen MH, Chak KF, Lin KS, and Tsai SJ explored the use of nucleic acid amplification technology in blood donor screening in Taiwan in their 2008 study "A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C," published in Transfusion.
Kumarasamy N, Balakrishnan P, Venkatesh KK, Srikrishnan AK, Cecelia AJ, Thamburaj E, Solomon S, and Mayer KH examined the prevalence and incidence of sexually transmitted infections among South Indians at high risk of HIV infection in their 2008 study published in AIDS Patient Care and STDs.
Okafor GO and Obi GO reported on the incidence of Hepatitis B surface antigen in Nigeria in their 1979 study published in Transactions of the Royal Society of Tropical Medicine and Hygiene.
Abiodun PO and Umoike IU studied HBs antigenaemia in Benin City, Nigeria, as reported in their 1990 study in Nigeria Journal of Pediatrics.
The risk of transfusion-transmitted viral infections was discussed by Schreiberer GB, Busch MP, Kleinman SH, and Kerolitz JJ in their 1996 study published in New England Journal of Medicine.
Iwarson S, Lindholm A, and Norkrans G investigated Hepatitis B and non-A, non-B infections in a Swedish blood center over ten years of HBsAg screening, as detailed in their 1980 study in Vox Sanguinis.
Tamim H, Aoun JP, Irani-Hakime N, Samaha H, Khoury S, and Almawi WY presented their findings on the seroprevalence of HCV infection among blood donors in a hospital-based study, published in Transfusion Aspheresis Science in 2001.
Nelson K, Ahmed F, Ness PM, Munoz A, Yawnk D, McAllister H, Stambolis V, and Donaline J assessed the efficacy of donor screening methods in reducing HCV transmission risk in their 1993 study in Transfusion.
Richards G, Holland P, Kuramoto K, Donville D, and Randell R examined the prevalence of hepatitis virus antibodies among blood donors in their 1991 study in Transfusion.
Shepard CW, Finelli L, and Alter MJ provided a global epidemiology overview of hepatitis C virus infection in their 2005 study in The Lancet Infectious Diseases.
Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, Detels R, and Bhattacharya SK analyzed HCV and HBV infection prevalence among HIV-positive intravenous drug users and their non-injecting wives in Manipur, India, as published in Indian Journal of Medical Research in 2000.
Amarapurkar DN, Kumar A, Vaidya S, Murti P, Bichile SK, Kalro RH, and Desai HG reported on the frequency of hepatitis B, C, D, and HIV infections in multi-transfused thalassemics in their 1992 study in Indian Journal of Gastroenterology.
Agarwal MB, Malkan GH, Bhave AA, Vishwanathan C, Billa V, Dube SR, Bajan K, Rajadhyaksha GC, and Shah SH discussed antibody prevalence to hepatitis C virus in multi-transfused thalassaemics in India in their 1993 study in Journal of the Association of Physicians of India.
Neogi DK, Bhattacharya N, Chakrabarti T, and Mukherjee KK presented a serological study on HCV activity in Kolkata, India, in their 1997 study in Journal of Communicable Diseases.
Kassu A, Mekonnen A, Bekele A, Abseno N, Melese E, Moges F, Wondmikun Y, and Ota F investigated HIV and syphilis infection among elderly people in northwest Ethiopia, as reported in their 2004 study in Japanese Journal of Infectious Diseases.
Yinnon AM, Coury-Doniger P, Polito R, and Reichman RC examined the serologic response to syphilis treatment in HIV-positive patients in their 1996 study in Archives of Internal Medicine.
Francis HL, Kabeya M, Kafuama N, Riggins C, Colebunders R, Ryder R, Curran J, Izaley L, and Quinn TC compared the sensitivities and specificities of latex agglutination and ELISA for detecting HIV antibodies in African sera in their 1988 study in Journal of Clinical Microbiology.
Riggin CH, Beltz GA, Hung CH, Thorn RM, and Marciani DJ evaluated the detection of HIV antibodies using latex agglutination with recombinant antigen in their 1987 study in Journal of Clinical Microbiology.
Iqbal HS, Solomon S, Murugavel KG, Solomon SS, and Balakrishnan P assessed the diagnostic usefulness of ELISA for detecting HIV-1 antibodies in India in their 2005 study in Clinical and Diagnostic Laboratories Immunology.
Khan JK, Lone DS, Hameed A, Munim MR, Bhatti M, Khattak AA, Usman M, Nadeem MF, Satti HS, and Munir M evaluated rapid immunochromatographic tests for detecting hepatitis B surface antigen and anti-HCV antibodies using ELISA-tested samples in their 2010 study.
Hussain T, Kulshreshtha KK, Sinha S, Yadav VS, and Katoch VM investigated HIV, HBV, HCV, and syphilis co-infections among STD clinic attendees in northern India in their 2006 study in International Journal of Infectious Diseases.
Khansari N, Mazhari SZ, and Rezvan H compared a rapid test and ELISA for HIV serological determination in their 1993 study in Acta Medica Iranica.
Lastly, the Central Drug Standard Control Organization provides guidelines and standards for blood safety in India, accessible at cdsco.nic.in.
Relevance: 9/10
Summary Feedback: The article appears to assess diagnostic tools for HIV, HBV, and HCV in India, focusing on ELISA and rapid tests. It compares methods across different regions and could provide valuable insights for healthcare in India.
Should be Published? Yes, contingent upon a thorough review of the full text for methodological soundness and conclusion strength.
Editorial Reviewer’s Mark
The article’s topic is highly relevant, addressing critical diagnostic methods in a region with significant public health challenges. While the references suggest a comprehensive approach, the full content’s quality is crucial for publication approval.
Donor screening, Blood safety, Infectious diseases, Hepatitis, HIV, Seroprevalence, Diagnostic testing, ELISA, Rapid tests, Nucleic acid amplification.
